Clinical and neurological mechanisms of pain development of various genesis of the maxillofacial region

Abstract

Pain of the maxillofacial region represents a highly complex clinical entity arising from diverse etiologies, including odontogenic, musculoskeletal, neuropathic, vascular, inflammatory, and idiopathic origins. Owing to the dense sensory innervation of the craniofacial structures by the trigeminal nerve and its extensive central projections, orofacial pain exhibits unique neurobiological and clinical characteristics distinct from pain in other body regions. The present review critically synthesizes current evidence on the clinical and neurological mechanisms underlying pain development of various genesis in the maxillofacial region, with emphasis on peripheral nociceptive activation, trigeminal pathway modulation, central sensitization, and neuroimmune interactions.

Peripheral sensitization begins with activation of Aδ and C fiber nociceptors in response to inflammatory mediators such as prostaglandins, bradykinin, cytokines, and neuropeptides. Ion channel modulation—including TRPV1, TRPA1, and voltage-gated sodium channel upregulation—lowers activation thresholds and promotes hyperexcitability. Persistent peripheral input induces functional and structural plasticity within the trigeminal ganglion and the spinal trigeminal nucleus (Vc), facilitating central sensitization characterized by enhanced glutamatergic transmission, NMDA receptor activation, and reduced inhibitory control. These processes contribute to clinical manifestations such as hyperalgesia, allodynia, and chronic persistent pain.

Neuropathic conditions such as trigeminal neuralgia, post-traumatic trigeminal neuropathy, and post-herpetic neuralgia arise from direct nerve injury or demyelination, resulting in ectopic discharges and aberrant synaptic transmission. In contrast, temporomandibular disorders and myofascial pain syndromes reflect a multifactorial interplay between peripheral tissue dysfunction and centrally mediated pain amplification. Increasing evidence highlights the role of glial activation, cytokine release, and neuroimmune signaling in maintaining chronic pain states within trigeminal pathways.

Advances in neuroimaging, quantitative sensory testing, and electrophysiological assessment have enhanced diagnostic precision by differentiating nociceptive from neuropathic mechanisms. Understanding the integration of peripheral pathology with central neuroplastic adaptation is essential for developing mechanism-based therapeutic strategies. Multimodal approaches targeting inflammatory pathways, ion channel modulation, and central sensitization mechanisms hold promise for improving clinical outcomes.

This review underscores the importance of a translational framework that bridges molecular neuroscience with clinical practice to optimize diagnosis, management, and prevention of chronic maxillofacial pain disorders.